Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $315.0 million.

  • Conmed's Total Current Liabilities rose 1327.11% to $315.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $315.0 million, marking a year-over-year increase of 1327.11%. This contributed to the annual value of $315.0 million for FY2025, which is 1327.11% up from last year.
  • Per Conmed's latest filing, its Total Current Liabilities stood at $315.0 million for Q4 2025, which was up 1327.11% from $314.7 million recorded in Q3 2025.
  • Over the past 5 years, Conmed's Total Current Liabilities peaked at $376.3 million during Q3 2023, and registered a low of $182.2 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $282.7 million (2024), whereas its average is $267.1 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 8042.04% in 2023, then plummeted by 2498.09% in 2024.
  • Conmed's Total Current Liabilities (Quarter) stood at $196.6 million in 2021, then soared by 50.8% to $296.6 million in 2022, then grew by 4.78% to $310.7 million in 2023, then decreased by 10.49% to $278.1 million in 2024, then grew by 13.27% to $315.0 million in 2025.
  • Its last three reported values are $315.0 million in Q4 2025, $314.7 million for Q3 2025, and $294.8 million during Q2 2025.